A Relative Bioavailability Study of LY3454738 in Healthy Participants
NCT06173895
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
30
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy
Interventions
DRUG:
LY3454738
Sponsor
Eli Lilly and Company